IFEZ 인천경제자유구역 로고

On Wednesday, July 3, 2024, Lotte Biologics held a groundbreaking ceremony for Lotte Biologics' Songdo Biologics Campus at the Songdo International City Advanced Industrial Cluster (11th tool). Lotte Biologics plans to have a world-class biopharmaceutical manufacturing facility through an investment of about KRW 4.6 trillion by 2030 in Songdo International City, and will build and operate three biopharmaceutical production plants (360,000 liters in total) on an area of 202,285㎡. In the case of Lotte Biologics' first plant (120,000 liters), it is possible to develop cell lines to produce finished products, and small incubators and finished drug facilities will be added for the production of clinical substances. In addition to its biopharmaceutical commissioned development and production (CDMO) business, Lotte Biologics is also promoting the 'Bio-Venture Initiative' for joint growth with bio ventures. Its main programs include providing space and research equipment for venture companies, technical support from global companies, and support for the commercialization of accelerators.